PCRX Next Earnings Date Notes

— Pacira BioSciences (NASDAQ: PCRX) is a specialty pharmaceutical company focused on non-opioid pain management, most notably through its flagship product, EXPAREL—a long-acting bupivacaine injection used to manage post-surgical pain. The company also markets iovera�b0, a handheld device for peripheral nerve block procedures, expanding its reach into innovative pain management solutions. As you prepare for the next PCRX earnings call, key performance metrics to watch include quarterly revenues (especially from EXPAREL), gross and operating margins, and product volume growth. Investors should also pay close attention to updates about hospital & ambulatory surgery center (ASC) adoption rates, since these channels are pivotal to EXPAREL’s growth. Pipeline progress and regulatory developments are crucial, as new indications or product releases can drive long-term value. Finally, keep an eye on cash flow & any changes to the company’s financial guidance, since managing R&D spending and leveraging operating efficiency are vital for sustainable growth in this competitive sector. The next projected earnings date for PCRX is 5/7/2026 after close (stay tuned for a confirmed earnings date once announced).

PCRX Next Earnings Date FAQ

On this page we presented the PCRX Next Earnings Date information for Pacira BioSciences along with recent past earnings dates. For Q4 of 2025, PCRX reported earnings of 0.570/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, PCRX reported earnings of 0.700/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, PCRX reported earnings of 0.740/share, with the earnings report taking place on 8/5/2025. For Q1 of 2025, PCRX reported earnings of 0.620/share, with the earnings report taking place on 5/8/2025. For Q4 of 2024, PCRX reported earnings of 0.910/share, with the earnings report taking place on 2/27/2025. Based on these past earnings dates, the projected next earnings date for PCRX is 5/7/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Pacira BioSciences. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Pacira BioSciences shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Pacira BioSciences next earnings dates as well as any other stock out there in our coverage universe, to see when the next PCRX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up PCRX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the PCRX next earnings date.